KSL Biomedical Inc. has entered the Canadian market with the acquisition of Burlington, Ontario-based Pulse Scientific Inc., extending its international base for product distribution and laboratory sales, while positioning KSL for future acquisitions in the Burlington/Toronto area and beyond.
Pulse Scientific is a privately-owned incorporation founded in 1992 that specializes in the supply of laboratory diagnostic tests for medical labs across Canada. Some examples of these tests include Syphillis, Rheumatoid Arthritis, drugs of abuse and microbiological products.
KSL Biomedical is a translational medicine technology company based in Williamsville, New York. KSL has been growing rapidly since its inception in 2017, fueled in part by its development of diagnostic and therapeutic applications for Covid-19 as well as in the areas of immunology, oncology, virology and genomics. The new acquisition creates KSL Biomedical Canada Inc., which specializes in the manufacturing and distribution of microbiology products and controls as well as in vitro diagnostic tests for labs and physicians.
This is a strategic deal for KSL. It brings with it an ISO 13485 certification and licensing by Health Canada, both of which will allow KSL to distribute in Canada, Europe and other international markets. These processes would have taken the company at least a year to complete on its own.
